We thank Dr. Lin and colleagues for their thoughtful comments regarding our systematic review, “In-Office Steroid Injections for Idiopathic Subglottic Stenosis: A Systematic Review.” We appreciate their interest in our work and their contribution to the evolving literature on serial intralesional steroid injections (SILSI). As noted in our Methods, the database search for our systematic review was conducted on April 5, 2025. 1 The prospective cohort study by Ying et al. 2 was published online on April 16, 2025, after completion of our search and study screening process. In accordance with standard systematic review methodology, only studies identified through the prespecified search window were eligible for screening and inclusion in the quantitative and narrative synthesis. For this reason, the Ying et al. 2 study was not incorporated into the results or figures of our review. At the time of manuscript preparation, however, the study had been published online and was therefore referenced in the introduction to acknowledge emerging prospective data on the topic. We agree with the authors that their work represents an important prospective contribution to the literature and provides additional evidence regarding the potential association between SILSI and prolonged surgery-free intervals in patients with idiopathic subglottic stenosis (iSGS). Given the rarity of iSGS and the limited number of prospective investigations available, continued publication of well-designed cohort studies such as that by Ying et al. 2 will be essential for refining our understanding of treatment effectiveness and guiding future research in this area. We appreciate the opportunity for scholarly dialogue and thank the authors for highlighting their important contribution to the field. The authors have nothing to report. The authors have nothing to report. The authors declare no conflicts of interest.
Rendon et al. (Mon,) studied this question.